Skip to main content

Kathryn Edwards Archives

NFID honors Edwards’ infectious diseases research

Nov. 16, 2017—Kathryn Edwards, MD, professor of Pediatrics and the Sarah H. Sell and Cornelius Vanderbilt Professor at Vanderbilt University School of Medicine, is the recipient of the 2018 Maxwell Finland Award for Scientific Achievement from the National Foundation for Infectious Diseases (NFID).

Read more

Reporter


Amoxicillin alone better choice for pediatric pneumonia: study

Nov. 9, 2017—A combination of two antibiotics is often prescribed to treat community-acquired pneumonia in children, but a JAMA Pediatrics study is now showing that using just one of the two has the same benefit to patients in most cases.

Read more

Health and Medicine Reporter Research


Edwards, Schaffner honored by major infectious diseases organizations

Oct. 26, 2017—Two highly regarded Vanderbilt University Medical Center (VUMC) infectious disease clinicians were recognized with service awards from prominent organizations during IDWeek in San Diego, California, Oct. 4-8.

Read more

Reporter


Forum highlights strong clinical, translational research efforts

Oct. 19, 2017—Clinical and translational research at Vanderbilt University Medical Center (VUMC) is thriving.

Read more

Health and Medicine Reporter Research Research Blog


Faculty members join March for Science

Apr. 27, 2017—Among the thousands of scientists and their supporters who participated in Saturday’s March for Science in Nashville and in Washington, D.C., were several faculty members from Vanderbilt University Medical Center and Vanderbilt University.

Read more

Reporter


VUSM’s MPH Program celebrates 20th anniversary

Nov. 10, 2016—The Vanderbilt University School of Medicine Master of Public Health (MPH) Program marked its 20th anniversary during Reunion Weekend in October.

Read more

Reporter


Creech to direct Vanderbilt Vaccine Research Program

Oct. 8, 2015—Buddy Creech, M.D., MPH, associate professor of Pediatrics, has been named director of the Vanderbilt Vaccine Research Program (VVRP) in the Division of Pediatric Infectious Diseases.

Read more

Health and Medicine Reporter Research Research Blog


Flu vaccine helps reduce hospitalizations due to influenza pneumonia: study

Oct. 6, 2015—More than half of hospitalizations due to influenza pneumonia could be prevented by influenza vaccination, according to a study led by investigators at Vanderbilt University Medical Center, published this week in the Journal of the American Medical Association.

Read more

Health and Medicine Healthcare Solutions Reporter Research


Study highlights pneumonia hospitalizations among U.S. adults

Jul. 15, 2015—Viruses, not bacteria, are the most commonly detected respiratory pathogens in U.S. adults hospitalized with pneumonia, according to a New England Journal of Medicine study released today and conducted by researchers at Centers for Disease Control and Prevention (CDC) and hospitals in Chicago and Nashville, including Vanderbilt University Medical Center.

Read more

Health and Medicine Healthcare Solutions Reporter Research Strategic Plan


Gates grant bolsters study of Tdap boosters in pregnant women

Jul. 9, 2015—Kathryn Edwards, M.D., director of the Vanderbilt Vaccine Research Program, has received a $307,000 grant from the Bill & Melinda Gates Foundation to study the immune responses of pregnant women who receive the Tdap (reduced-dose acellular pertussis vaccines combined with tetanus and diphtheria toxoids) vaccine.

Read more

Healthcare Solutions Reporter Research Research Blog Strategic Plan


VUMC Academic Enterprise Faculty Award winners announced

May. 26, 2015—The 2015 Vanderbilt University Medical Center Academic Enterprise Faculty Awards, which were presented during the May 19 Spring Faculty meeting, included awards for Excellence in Teaching and Outstanding Contributions to Research.

Read more

Reporter


VU joins national effort to speed Ebola therapy testing

Apr. 8, 2015—Vanderbilt University researchers have joined a multi-center effort led by Pennsylvania-based Inovio Pharmaceuticals Inc. to accelerate development of potential antibody therapies against the often-lethal Ebola virus.

Read more

Health and Medicine Reporter Research


Page 1 of 3123